Nektar Therapeutics (NKTR)

72.57 +1.46 (+2.05%) USD  |  NASDAQ  |  Mar 05, 15:40
More

Nektar Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Rigel Pharmaceuticals, Inc. Upgrade
Insmed, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade